跳至主要内容
临床试验/NCT06628544
NCT06628544已完成早期 1 期

The Role of Trained Immunity in Fungal Infection and the Mechanism Behind it

Zhongnan Hospital1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
79
试验地点
1
主要终点
The level of IL-6

研究概览

简要总结

Investigator vaccinated 76 healthy BCG-naive participant with BCG, while 3 participants received. Half of BCG-vaccinated participants (n = 38) received an incremental dose of metformin for 6 days (up to 1,000 mg twice daily on day 6). On the day 0 (total 20; n = 10 for BCG vaccination, n = 10 for BCG vaccination plus taking metformin), day 14 (total 30; n=15 for BCG vaccination, n = 15 for BCG vaccination plus taking metformin), day 90 (total 26; n = 13 for BCG vaccination, n=13 for BCG vaccination plus taking metformin) of BCG vaccination, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy BCG-naive participants.
  • The ages range from 20 to
  • Participants without any infections or immune deficiencies.

排除标准

  • Participants when infections or other illnesses occurred during the clinical trial.
  • Participants who have a fever of unknown causes during the clinical trial.
  • Participants who have gotten other vaccines during the clinical trial.

研究组 & 干预措施

BCG vaccination with taking metformin on the day 85

Experimental

干预措施: BCG vaccination (Biological)

BCG vaccination with taking metformin on the day 85

Experimental

干预措施: Metformin is administered on the day 85 (Drug)

BCG vaccination without metformin

Experimental

干预措施: BCG vaccination (Biological)

Placebo

Placebo Comparator

干预措施: Placebo (Other)

BCG vaccination with taking metformin on the day 0

Experimental

干预措施: BCG vaccination (Biological)

BCG vaccination with taking metformin on the day 0

Experimental

干预措施: Metformin is administered on the day 0 (Drug)

BCG vaccination with taking metformin on the day 9

Experimental

干预措施: BCG vaccination (Biological)

BCG vaccination with taking metformin on the day 9

Experimental

干预措施: Metformin is administered on the day 9 (Drug)

结局指标

主要结局

The level of IL-6

时间窗: Five days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis

After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.

The level of TGF-alpha

时间窗: Five days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis

After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.

次要结局

未报告次要终点

研究者

发起方
Zhongnan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhibing Lu

Professor

Zhongnan Hospital

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS)innate immune memorytrained immunity1002766510002252
NL-OMON49014Radboud Universitair Medisch Centrum100
尚未招募
不适用
Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS)COVID-19, SARS-CoV-2
NL-OMON27545Radboudumc100
进行中(未招募)
1 期
Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS)Trained immunityCOVID-19This study will investigate whether oral bisphosphonate supplementation or the MMR vaccine can be used as immune potentiators when simultaneously administered with BCG, to further amplify the BCG-induced trained immunity response and maximize potential protective effects against COVID-19.
EUCTR2020-002456-21-NLRadboudumc100
Unknown
不适用
IMMUNE RESPONSE INDUCED BY VACCINATION WITH BCGlocal pain, irritation or discomfort at the injection site (immediately after the injection)=commonuncommon= headache, fever localenlargement of regional lymph node >1cm. Ulceration with a severe discharging ulcer at the site of injection.Rare: disseminated BCG complications such as osteitis or osteomyelitis, allergic reactions, including anaphylactic reactions. Local suppurative lymphadenitis, abscess formation.
NL-OMON29225Performer; University Medical Center25
已完成
不适用
Immune repons induced by vaccination with BCGImmuunresponse by BCG vaccination Tuberculosis10028440
NL-OMON37373eids Universitair Medisch Centrum25